Literature DB >> 1768744

Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-alpha) on human leucocytes.

L Paulesu1, E Luzzi, V Bocci.   

Abstract

The effect of ozone as a probable inducer of tumor necrosis factor (TNF-alpha) has been investigated on human blood and on Ficoll-purified blood mononuclear cells (PBMC). Samples were exposed at different ozone concentrations ranging from 2.2 to 108 micrograms/ml and incubated at 37 degrees C in an 95% air-5% CO2 atmosphere. At predetermined times, all cell supernatants were tested for TNF activity and some PBMC cultures were examined for DNA synthesis. We have shown that ozone concentration is critical in terms of TNF production and of cell mitogenesis and that, owing to the presence of erythrocytes, higher ozone concentrations are required to be effective in blood than in PBMC. Because ozonization of blood is a procedure followed in several European countries for the treatment of viral diseases and tumors, the release of factors with antiviral and immunomodulatory activities by leukocytes may explain the mechanism of action of ozone and of autohemotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768744

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  15 in total

1.  The Morphometrical and Histopathological Changes which were Observed after Topical Ozone Therapy on an Exophytic Fibrous Gingival Lesion: A Case Report.

Authors:  Punit Vaibhav Patel; Sheela Kumar Gujjari
Journal:  J Clin Diagn Res       Date:  2013-06-01

2.  Associations of tumor necrosis factor G-308A with childhood asthma and wheezing.

Authors:  Yu-Fen Li; W James Gauderman; Ed Avol; Louis Dubeau; Frank D Gilliland
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

3.  Effects of ozone on some biological activities of cells in vitro.

Authors:  V Cardile; X Jiang; A Russo; F Casella; M Renis; M Bindoni
Journal:  Cell Biol Toxicol       Date:  1995-02       Impact factor: 6.691

4.  Does intraperitoneal medical ozone preconditioning and treatment ameliorate the methotrexate induced nephrotoxicity in rats?

Authors:  Arif Aslaner; Tuğrul Çakır; Betül Çelik; Uğur Doğan; Burhan Mayir; Cebrail Akyüz; Cemal Polat; Ahmet Baştürk; Vural Soyer; Süleyman Koç; Ahmet Özer Şehirli
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  The protective effect of intraperitoneal medical ozone preconditioning and treatment on hepatotoxicity induced by methotrexate.

Authors:  Arif Aslaner; Tuğrul Çakır; Betül Çelik; Uğur Doğan; Cebrail Akyüz; Ahmet Baştürk; Cemal Polat; Umut Gündüz; Burhan Mayir; Ahmet Özer Şehirli
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Five and ten year follow-up on intradiscal ozone injection for disc herniation.

Authors:  Josip Buric; Luca Rigobello; David Hooper
Journal:  Int J Spine Surg       Date:  2014-12-01

Review 7.  Ozone and cardiovascular injury.

Authors:  Vera Srebot; Emilio A L Gianicolo; Giuseppe Rainaldi; Maria Giovanna Trivella; Rosa Sicari
Journal:  Cardiovasc Ultrasound       Date:  2009-06-24       Impact factor: 2.062

8.  Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production.

Authors:  V Bocci; G Valacchi; F Corradeschi; G Fanetti
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role.

Authors:  V Bocci
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Ambient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study.

Authors:  Gilaad G Kaplan; Divine Tanyingoh; Elijah Dixon; Markey Johnson; Amanda J Wheeler; Robert P Myers; Stefania Bertazzon; Vineet Saini; Karen Madsen; Subrata Ghosh; Paul J Villeneuve
Journal:  Environ Health Perspect       Date:  2013-07-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.